{"id":4660,"date":"2025-08-13T08:42:09","date_gmt":"2025-08-12T22:42:09","guid":{"rendered":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/australias-drug-prevention-crisis-where-were-failing-and-the-urgent-need-for-change-2\/"},"modified":"2025-08-13T08:42:09","modified_gmt":"2025-08-12T22:42:09","slug":"australias-drug-prevention-crisis-where-were-failing-and-the-urgent-need-for-change-2","status":"publish","type":"post","link":"https:\/\/www.dalgarnoinstitute.org.au\/wp_site\/australias-drug-prevention-crisis-where-were-failing-and-the-urgent-need-for-change-2\/","title":{"rendered":"Australia\u2019s Drug Prevention Crisis: Where We\u2019re Failing and the Urgent Need for Change"},"content":{"rendered":"

\"gandfullofpills\"The United Nations Office on Drugs and Crime\u2019s World Drug Report 2025 delivers a The United Nations Office on Drugs and Crime\u2019s World Drug Report 2025 delivers a sobering wake-up call for Australia\u2019s drug prevention crisis. Meanwhile, whilst policymakers debate harm reduction strategies and law enforcement approaches, the nation is haemorrhaging lives and resources to preventable drug-related harm. Moreover, the data reveals we\u2019re not just losing the war on drugs \u2013 we\u2019re actively retreating from the battlefield where victory is most achievable: prevention and recovery.<\/p>\n

Furthermore, Australia\u2019s drug prevention crisis has reached critical levels, with our position as a global outlier in drug consumption alarming every parent, educator, and community leader. However, this isn\u2019t just about statistics \u2013 it\u2019s about the devastating reality that our current approach is failing the very people we\u2019re meant to protect.<\/p>\n

Australia: A Global Leader in Drug Consumption<\/strong><\/p>\n

The World Drug Report 2025 places Australia in an uncomfortable spotlight as a world leader in several disturbing categories. Specifically, against a global backdrop of 316 million people using drugs in 2023 \u2013 with cannabis dominating at 244 million users, followed by opioids (61 million), amphetamines (31 million), cocaine (25 million), and \u201cecstasy\u201d (21 million) \u2013 Australia\u2019s consumption rates are alarmingly disproportionate.<\/p>\n

Cocaine Crisis<\/strong>: First, Australia holds the unwelcome distinction of having the highest past-year cocaine use globally<\/strong> in the Australia and New Zealand subregion. Nevertheless, the report notes that whilst consumption based on wastewater analysis is \u201cclearly lower than in other parts of the world,\u201d suggesting most users are occasional rather than regular consumers, this pattern actually masks a more insidious problem \u2013 widespread experimentation that can rapidly escalate to dependency.<\/p>\n

\u201cEcstasy\u201d Epidemic<\/strong>: Even more concerning is Australia\u2019s status as having \u201cby far the highest\u201d global prevalence of \u201cecstasy\u201d use worldwide<\/strong>. Indeed, this statistic exemplifies the Australia drug prevention crisis \u2013 it represents hundreds of thousands of Australians, many of them young people, exposing themselves to substances with unpredictable purity and potentially fatal consequences.<\/p>\n

Cannabis Concerns<\/strong>: Similarly, cannabis use remains \u201csignificantly higher than the global average, with prevalence of use exceeding 12 per cent\u201d in Australia and New Zealand. Particularly troubling, amongst school students aged 15-16, the prevalence sits at 13 per cent, compared to the global average of just 4.4 per cent. Additionally, this occurs in a global context where cannabis accounts for 244 million users worldwide \u2013 making it the most widely used illicit substance globally.<\/p>\n

The Treatment Gap: A System in Crisis<\/strong><\/p>\n

Perhaps most damning is the treatment data. Globally, only 64 million people with drug use disorders received treatment in 2023 \u2013 a mere 8.1% of the population needing help, with stark gender disparities (1 in 18 women versus 1 in 7 men accessing treatment). Consequently, against this global treatment crisis, Australia\u2019s specific failures become even more stark.<\/p>\n

Importantly, the report reveals that over 40 per cent of those in drug-related treatment in Australia and New Zealand are being treated for methamphetamine use disorder<\/strong> \u2013 the highest proportion globally. Furthermore, adding to this concerning picture, Oceania leads the world with 35% of people in drug treatment being women<\/strong>, compared to just 32% in the Americas, 20% in Europe, 13% in Africa, and only 8% in Asia. Therefore, this statistic exposes two critical failures:<\/p>\n

    \n
  1. Prevention Failure<\/strong>: Clearly, the sheer volume of people requiring methamphetamine treatment indicates our prevention efforts have been woefully inadequate.<\/li>\n
  2. Recovery Gap<\/strong>: Meanwhile, whilst we\u2019re treating people after they\u2019ve developed severe dependencies, we\u2019re missing countless opportunities for early intervention and prevention.<\/li>\n<\/ol>\n

    Subsequently, the report notes that people in drug-related treatment in Australia and New Zealand are \u201crelatively young, in particular in Australia, where 55 per cent are under the age of 35.\u201d Consequently, this demographic should be our biggest red flag \u2013 the Australia drug prevention crisis is losing an entire generation to preventable drug harm. Significantly, Australia and New Zealand rank amongst the highest for young people in treatment at 25%, exceeded only by regions facing severe socioeconomic crises like South America (50%) and conflict-affected areas such as the Near and Middle East (35%).<\/p>\n

    The Methamphetamine Reality Check<\/strong><\/p>\n

    The World Drug Report provides a stark assessment of Australia\u2019s methamphetamine situation:<\/p>\n